Drug companies have limited resources, just like every other business. Drug companies answer to their stockholders and have to weigh where to put their funds. It is not surprising that when an emergent situation is no longer an emergency, focus shifts elsewhere. You can never go back and predict that something will be needed. Difficult decisions.